LEO Pharma And PellePharm Announce $760 Million Collaboration To Advance Innovative Therapies For Rare Skin Diseases

Tuesday, November 20, 2018 1 min read

Key Takeaway: LEO Pharma And PellePharm Announce $760 Million Collaboration To Advance Innovative Therapies For Rare Skin Diseases

Full Press Release Details

LEO Pharma And PellePharm Announce $760 Million Collaboration To Advance Innovative Therapies For Rare Skin Diseases.